Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles

Virus Research

Volumn 191, Issue 1, 2014, Pages 30-38

  Wang, Xin ^a   Li, Xiaoyu ^a   Ma, Jing ^b   Zhang, Li ^c   Ma, Ling ^a   Mi, Zeyun ^a   Zhou, Jinming ^a   Guo, Fei ^d   Kleiman, Lawrence ^b   Cen, Shan ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

APOBEC3F; APOBEC3G; HIV 1; Incorporation; NC

Indexed keywords

AMINO ACID; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; CYTIDINE DEAMINASE; GAG PROTEIN; ZINC FINGER PROTEIN; APOBEC3F PROTEIN, HUMAN; CYTOSINE DEAMINASE;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; CHEMISTRY; ENZYMOLOGY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CYTOSINE DEAMINASE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; VIRION; VIRUS ASSEMBLY; ZINC FINGERS;

EID: 84922383175     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.07.011     Document Type: Article

References (41)

1. Accola M.A., Ohagen A., Gottlinger H.G. Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag). J. Virol. 2000, 74(13):6198-6202.
2. Bach D., Peddi S., Mangeat B., Lakkaraju A., Strub K., Trono D. Characterization of APOBEC3G binding to 7SL RNA. Retrovirology 2008, 5:54.
3. Berger G., Durand S., Fargier G., Nguyen X.N., Cordeil S., Bouaziz S., Muriaux D., Darlix J.L., Cimarelli A. APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 2011, 7(9):e1002221.
4. Bishop K.N., Holmes R.K., Malim M.H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 2006, 80(17):8450-8458.
5. Bourara K., Liegler T.J., Grant R.M. Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1. PLoS Pathog. 2007, 3(10):1477-1485.
6. Buckman J.S., Bosche W.J., Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid Zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 2003, 77(2):1469-1480.
7. Cen S., Guo F., Niu M., Saadatmand J., Deflassieux J., Kleiman L. The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 2004, 279(32):33177-33184.
8. Cen S., Niu M., Saadatmand J., Guo F., Huang Y., Nabel G.J., Kleiman L. Incorporation of Pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol. J. Virol. 2004, 78(2):1042-1049.
9. Chiu Y.L., Greene W.C. APOBEC3G: an intracellular centurion. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2009, 364(1517):689-703.
10. Conticello S.G. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 2008, 9(6):229.
11. Dang Y., Siew L.M., Wang X., Han Y., Lampen R., Zheng Y.H. Human cytidine deaminase APOBEC3H restricts HIV-1 replication. J. Biol. Chem. 2008, 283(17):11606-11614.
12. Dang Y., Wang X., Esselman W.J., Zheng Y.H. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol. 2006, 80(21):10522-10533.
13. Dang Y., Wang X., York I.A., Zheng Y.H. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. J. Virol. 2010, 84(17):8561-8570.
14. Didierlaurent L., Houzet L., Morichaud Z., Darlix J.L., Mougel M. The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation. Nucleic Acids Res. 2008, 36(14):4745-4753.
15. Doehle B.P., Schafer A., Cullen B.R. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology 2005, 339(2):281-288.
16. Ebrahimi D., Anwar F., Davenport M.P. APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome. Retrovirology 2012, 9:113.
17. Grigorov B., Decimo D., Smagulova F., Pechoux C., Mougel M., Muriaux D., Darlix J.L. Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers. Retrovirology 2007, 4:54.
18. Guo J., Wu T., Anderson J., Kane B.F., Johnson D.G., Gorelick R.J., Henderson L.E., Levin J.G. Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J. Virol. 2000, 74(19):8980-8988.
19. Holmes R.K., Koning F.A., Bishop K.N., Malim M.H. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 2007, 282(4):2587-2595.
20. Huthoff H., Malim M.H. Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation. J. Virol. 2007, 81(8):3807-3815.
21. Imahashi M., Nakashima M., Iwatani Y. Antiviral mechanism and biochemical basis of the human APOBEC3 family. Front. Microbiol. 2012, 3:250.
22. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002, 79(3):285-296.
23. Kafaie J., Song R., Abrahamyan L., Mouland A.J., Laughrea M. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging. Virology 2008, 375(2):592-610.
24. Khan M.A., Goila-Gaur R., Kao S., Miyagi E., Walker R.C., Strebel K. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization. Retrovirology 2009, 6:99.
25. LaRue R.S., Andresdottir V., Blanchard Y., Conticello S.G., Derse D., Emerman M., Greene W.C., Jonsson S.R., Landau N.R., Lochelt M., Malik H.S., Malim M.H., Munk C., O'Brien S.J., Pathak V.K., Strebel K., Wain-Hobson S., Yu X.F., Yuhki N., Harris R.S. Guidelines for naming nonprimate APOBEC3 genes and proteins. J. Virol. 2009, 83(2):494-497.
26. Lassen K.G., Wissing S., Lobritz M.A., Santiago M., Greene W.C. Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif. J. Biol. Chem. 2010, 285(38):29326-29335.
27. Luo K., Liu B., Xiao Z., Yu Y., Yu X., Gorelick R., Yu X.F. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J. Virol. 2004, 78(21):11841-11852.
28. Mark-Danieli M., Laham N., Kenan-Eichler M., Castiel A., Melamed D., Landau M., Bouvier N.M., Evans M.J., Bacharach E. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity. J. Virol. 2005, 79(12):7756-7767.
29. Miyagi E., Brown C.R., Opi S., Khan M., Goila-Gaur R., Kao S., Walker R.C., Hirsch V., Strebel K. Stably expressed APOBEC3F has negligible antiviral activity. J. Virol. 2010, 84(21):11067-11075.
30. Ottmann M., Gabus C., Darlix J.L. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 1995, 69(3):1778-1784.
31. Rogozin I.B., Basu M.K., Jordan I.K., Pavlov Y.I., Koonin E.V. APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle 2005, 4(9):1281-1285.
32. Russell R.A., Smith J., Barr R., Bhattacharyya D., Pathak V.K. Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. J. Virol. 2009, 83(4):1992-2003.
33. Thomas J.A., Gagliardi T.D., Alvord W.G., Lubomirski M., Bosche W.J., Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology 2006, 353(1):41-51.
34. Ulenga N.K., Sarr A.D., Thakore-Meloni S., Sankale J.L., Eisen G., Kanki P.J. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. J. Infect. Dis. 2008, 198(4):486-492.
35. Wang T., Tian C., Zhang W., Luo K., Sarkis P.T., Yu L., Liu B., Yu Y., Yu X.F. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G. J. Virol. 2007, 81(23):13112-13124.
36. Wang T., Tian C., Zhang W., Sarkis P.T., Yu X.F. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging. J. Mol. Biol. 2008, 375(4):1098-1112.
37. Wang X., Dolan P.T., Dang Y., Zheng Y.H. Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle. J. Biol. Chem. 2007, 282(3):1585-1594.
38. Yang Y., Guo F., Cen S., Kleiman L. Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F. Virology 2007, 365(1):92-100.
39. Zhang L., Li X., Ma J., Yu L., Jiang J., Cen S. The incorporation of APOBEC3 proteins into murine leukemia viruses. Virology 2008, 378(1):69-78.
40. Zhang W., Du J., Yu K., Wang T., Yong X., Yu X.F. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions. J. Virol. 2010, 84(24):12903-12913.
41. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 2004, 78(11):6073-6076.